✦ LIBER ✦

Targets for Alzheimer's disease research: From basic mechanisms to rational therapies

✍ Scribed by Sam Gandy

Book ID: 119145096
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 408 KB
Volume: 15
Category: Article
ISSN: 0197-4580
DOI: 10.1016/0197-4580(94)90195-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Target molecules for anti-angiogenic the

Target molecules for anti-angiogenic therapy: from basic research to clinical trials

✍ Martin Hagedorn; Andreas Bikfalvi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 280 KB

There is growing evidence that anti-angiogenic drugs will improve future therapies of diseases like cancer, rheumatoid arthritis and ocular neovascularisation. However, it is still uncertain which kind of substance, out of the large number of angiogenesis inhibitors, will prove to be a suitable agen

Invited Review Cholinesterase inhibitors

Invited Review Cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications

✍ Ezio Giacobini 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 187 KB

From dissection of disease pathogenesis

From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era

✍ Guang-biao ZHOU; Guo LI; Sai-juan CHEN; Zhu CHEN 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 Chinese ⚖ 327 KB

Screening of treatment targets for Alzhe

Screening of treatment targets for Alzheimer’s disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation

✍ Lian-Feng Lin; Huan-Min Luo 📂 Article 📅 2011 🏛 Shanghai Institutes for Biological Sciences, Chine 🌐 English ⚖ 755 KB

Handbook of Neurochemistry and Molecular

Handbook of Neurochemistry and Molecular Neurobiology Volume 810 || Neuroprotective Mechanisms: Oxidative Stress as a Target for Neuroprotective Therapies in Alzheimer's and Parkinson's Disease

✍ Lajtha, Abel; Youdim, Moussa B. H.; Riederer, Peter; Mandel, Sylvia A.; Battisti 📂 Article 📅 2007 🏛 Springer US ⚖ 301 KB

Emerging Drugs and Targets for Alzheimer

Emerging Drugs and Targets for Alzheimer's Disease Volume 1 || Chapter 9. Tau Protein Kinases Inhibitors: From the Bench to the Clinical Trials

✍ Martinez, Ana 📂 Article 📅 2010 🏛 Royal Society of Chemistry ⚖ 570 KB